A multivariate study focused on the analysis of CD44 isoforms in 34 adult patients with myxofibrosarcoma showed that increased expression of CD44s and reduced expression of CD44v6 isoform correlated significantly with an improved outcome (p<0.05 and p<0.02, respectively) (156). Here, CD44 is linked to myxofibrosarcoma.